A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus

NCT04678557 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient functional product engraftment

Conditions

Type 1 Diabetes

Interventions

COMBINATION_PRODUCT: VC-01 Combination Product

Sponsor

ViaCyte